Growth inhibition of cultured human gastric cancer coils by 9-cis-retinoic acid with induction of cdk inhibitor Waf1/Cip1/Sdi1/p21 protein

被引:30
作者
Naka, K
Yokozaki, H
Domen, T
Hayashi, K
Kuniyasu, H
Yasui, W
Lotan, R
Tahara, E
机构
[1] HIROSHIMA UNIV,SCH MED,DEPT PATHOL 1,MINAMI KU,HIROSHIMA 734,JAPAN
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT TUMOR BIOL,HOUSTON,TX 77030
关键词
D O I
10.1046/j.1432-0436.1997.6150313.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The effect of 9-cis-retinoic acid (9-cis-RA) on the growth of eight gastric cancer cell lines was related to their transcription levels of mRNAs for retinoid receptors. Northern blot analysis showed that seven (TMK-1, MKN-1, -28, -45, -74, HSC-39, KATO-III) out of eight gastric cancer cell lines synthesized mRNAs for retinoic acid receptors (RARs) and retinoid X receptor-alpha (RXR-alpha). MKN-7 cells did not transcribe either RARs or RXR-alpha at the mRNA level although they appeared to have no alterations at the gene level. The growth of all of the cell Lines except for MKN-7 cells was inhibited by 1 x 10(-6) M 9-cis-RA. Cell cycle distribution analysis revealed that G(0)-G(1) arrest was not induced by exposure to 9-cis-RA in the sensitive TMK-1 and KATO-III cells or the resistant MKN-7 cells. Interestingly, 9-cis-RA temporarily increased the amount of the cyclin dependent kinase (cdk) inhibitor, Waf1/Cip1/Sdi1/p21 protein, and also reduced the amount of cdk-7, epidermal growth factor receptor (EGFR) and cyclin D1 proteins, followed by reduction in phosphorylation of the product of the retinoblastoma tumor suppressor gene (Rb) in the sensitive TMK-1 cells, but not in the resistant MKN-7 cells. These results suggest that 9-cis-RA has a cytostatic effect on gastric cancer cells that synthesize the receptor molecules through cell cycle regulatory machinery.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 52 条
[1]   Inhibition of cell growth by transforming growth factor beta 1 is associated with p53-independent induction of p21 in gastric carcinoma cells [J].
Akagi, M ;
Yasui, W ;
Akama, Y ;
Yokozaki, H ;
Tahara, H ;
Haruma, K ;
Kajiyama, G ;
Tahara, E .
JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (04) :377-384
[2]   Chemoprevention of mammary carcinogenesis in the rat: Combined use of raloxifene and 9-cis-retinoic acid [J].
Anzano, MA ;
Peer, CW ;
Smith, JM ;
Mullen, LT ;
Shrader, MW ;
Logsdon, DL ;
Driver, CL ;
Brown, CC ;
Roberts, AB ;
Sporn, MB .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (02) :123-125
[3]  
BURGER C, 1994, J CELL SCI, V107, P2047
[4]   Role of CBP/P300 in nuclear receptor signalling [J].
Chakravarti, D ;
LaMorte, VJ ;
Nelson, MC ;
Nakajima, T ;
Schulman, IG ;
Juguilon, H ;
Montminy, M ;
Evans, RM .
NATURE, 1996, 383 (6595) :99-103
[5]  
COHEN PS, 1995, CANCER RES, V55, P2380
[6]   A NOVEL CYCLIN ASSOCIATES WITH MO15/CDK7 TO FORM THE CDK-ACTIVATING KINASE [J].
FISHER, RP ;
MORGAN, DO .
CELL, 1994, 78 (04) :713-724
[7]   Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines [J].
Grandis, JR ;
Zeng, Q ;
Tweardy, DJ .
NATURE MEDICINE, 1996, 2 (02) :237-240
[8]   9-CIS RETINOIC ACID IS A HIGH-AFFINITY LIGAND FOR THE RETINOID-X RECEPTOR [J].
HEYMAN, RA ;
MANGELSDORF, DJ ;
DYCK, JA ;
STEIN, RB ;
EICHELE, G ;
EVANS, RM ;
THALLER, C .
CELL, 1992, 68 (02) :397-406
[9]  
Hong WK, 1995, CLIN CANCER RES, V1, P677
[10]   USE OF ALL-TRANS RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA [J].
HUANG, ME ;
YE, YC ;
CHEN, SR ;
CHAI, JR ;
LU, JX ;
ZHOA, L ;
GU, LJ ;
WANG, ZY .
BLOOD, 1988, 72 (02) :567-572